Localized Digestive Neuroendocrine Carcinomas clinical trials

Explore recruiting localized digestive neuroendocrine carcinomas clinical trials.

Recruiting localized digestive neuroendocrine carcinomas studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Localized Digestive Neuroendocrine Carcinomas trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II study to evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendocrine carcinomas - NEONEC D19-01

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II study to evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendocrine carcinomas - NEONEC D19-01

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Localized Digestive Neuroendocrine Carcinomas trials by city

Localized Digestive Neuroendocrine Carcinomas in Toronto Localized Digestive Neuroendocrine Carcinomas in Vancouver Localized Digestive Neuroendocrine Carcinomas in Montreal Localized Digestive Neuroendocrine Carcinomas in Calgary Localized Digestive Neuroendocrine Carcinomas in Edmonton Localized Digestive Neuroendocrine Carcinomas in Ottawa Localized Digestive Neuroendocrine Carcinomas in Winnipeg Localized Digestive Neuroendocrine Carcinomas in Quebec City Localized Digestive Neuroendocrine Carcinomas in Hamilton Localized Digestive Neuroendocrine Carcinomas in Kitchener Localized Digestive Neuroendocrine Carcinomas in London Localized Digestive Neuroendocrine Carcinomas in Halifax Localized Digestive Neuroendocrine Carcinomas in New York Localized Digestive Neuroendocrine Carcinomas in Los Angeles Localized Digestive Neuroendocrine Carcinomas in Chicago Localized Digestive Neuroendocrine Carcinomas in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease